News Room

Who We Are

A more than 25 year old global pharmaceutical business development firm, with a successful track record and an excellent reputation with both big pharma and smaller pharmaceutical and biotech companies.

We:

  • execute product and compound acquisition and
    divestment transactions.
  • execute product and compound in-licensing and
    out-licensing transactions.
  • provide strategic advice.

What We Offer

We have perfected our methodology over the years and have become very efficient at delivering the results our demanding clients expect.

With the objective to achieve a broad geographic presence, our partners and senior consultants are based in Barcelona, Basel, Beijing, Indianapolis, London, Los Angeles, Milan, Oxford, Philadelphia, Sao Paulo and Tokyo.

We are team players who are used to working on complex assignments and to utilizing out of the box¬Ě thinking in order to succeed in an extremely competitive environment.

We have built a network of industry professionals that have experience working with us and are glad to provide us with the best references. This network also provides us with additional sources of knowledge, referrals and advice.

What We Look For

We wish to expand our team and thus seek experienced pharmaceutical executives with strong local knowledge and deep industry relationships to augment our business in certain key markets (e.g. France, Germany and CEE countries).

Qualified applicants should possess:

  • entrepreneurial instincts and interests;
  • minimum 10-15 years of pharmaceutical industry experience;
  • ethical and/or OTC business development knowledge and contacts;
  • pertinent language fluency; and
  • prior executive roles in large pharmaceutical and/or development-stage companies.

While we are mainly interested in individuals, applications from small consulting companies that would create synergy with our organization shall also be given consideration.

Contact us at info@plexusventures.com to discuss whether Plexus Ventures suits your future plans.